EC Healthcare (HK:2138) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
EC Healthcare has issued a profit warning for investors, indicating an expected decrease in EBITDA by not more than 10% and a significant drop in net profit to no more than HK$25 million for the year ended 31 March 2024, in comparison to the previous year. Reasons for the decline include increased interest expenses, lower operation leverage at new service points, inflation-related operating costs, and reduced government subsidies. The company’s final financial results are still pending, and investors are urged to exercise caution when dealing in the company’s shares.
For further insights into HK:2138 stock, check out TipRanks’ Stock Analysis page.